Cargando…
Dientamoeba fragilis – the most common intestinal protozoan in the Helsinki Metropolitan Area, Finland, 2007 to 2017
BACKGROUND: Despite the global distribution of the intestinal protozoan Dientamoeba fragilis, its clinical picture remains unclear. This results from underdiagnosis: microscopic screening methods either lack sensitivity (wet preparation) or fail to reveal Dientamoeba (formalin-fixed sample). AIM: In...
Autores principales: | Pietilä, Jukka-Pekka, Meri, Taru, Siikamäki, Heli, Tyyni, Elisabet, Kerttula, Anne-Marie, Pakarinen, Laura, Jokiranta, T Sakari, Kantele, Anu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6652114/ https://www.ncbi.nlm.nih.gov/pubmed/31339096 http://dx.doi.org/10.2807/1560-7917.ES.2019.24.29.1800546 |
Ejemplares similares
-
Treatment of Dientamoeba fragilis: A retrospective Finnish analysis of faecal clearance and clinical cure comparing four antiprotozoal drugs
por: Pietilä, Jukka-Pekka, et al.
Publicado: (2023) -
Dientamoeba fragilis in Gaza Strip: a Neglected Protozoan Parasite
por: Al-Hindi, Adnan I., et al.
Publicado: (2013) -
Fatal Babesiosis in Man, Finland, 2004
por: Haapasalo, Karita, et al.
Publicado: (2010) -
Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment
por: Burgaña, Ander, et al.
Publicado: (2019) -
Evaluation of microscopy and PCR for detection of Dientamoeba fragilis
por: Tolba, Mona Mohamed, et al.
Publicado: (2022)